comparemela.com

Latest Breaking News On - சாங் க்குவொன் - Page 1 : comparemela.com

Preparations for Ukraine Reform Conference in Switzerland discussed at President s Office

Monday, 22 March 2021, 02:36 Preparations for Ukraine Reform Conference in Switzerland discussed at President s Office 26.02.2021 15:43 Ukrinform Deputy Head of the Office of the President of Ukraine Ihor Zhovkva and Head of the Agency of Diplomatic Advisers to the President of Switzerland Térence Billeter discussed in a phone call preparations for the Ukraine Reform Conference to be held in Switzerland in 2022. This was reported by the press service of the President s Office on February 25. The interlocutors discussed topical issues of bilateral relations and the implementation of agreements reached as a result of the official visit of President of the Swiss Confederation Simonetta Sommaruga to Ukraine in July 2020.

Ukrinform: Ukrainian official, South Korean ambassador discuss exchange of high-level visits | KyivPost

© 1995-2021 Businessgroup LLC All materials, including photographs, contained on this site are protected by copyright law and may not be reproduced without the prior written permission of Businessgroup LLC at news@kyivpost.com. All Interfax-Ukraine news agency stories cannot be reproduced or distributed in any form without written permission of Interfax-Ukraine. Translate » Dear reader, This is a friendly reminder that you should switch off your ad-blocker while visiting the Kyiv Post. We respect and understand your choice to avoid advertising, but most ad-blockers also prevent pages from fully loading, stop our site from functioning to its highest potential and block login, register functions and more.

Hanmi Pharmaceutical expects U S FDA approval for 2 new drugs

LAPSTriple Agonist, an innovative triple-acting new drug for NASH treatment, indication expansion Efpeglenatide met the primary endpoint for global Phase 3 Striving for developing rare diseases such as a once-a-month drug for short-bowel syndrome SEOUL, South Korea, Jan. 18, 2021 /PRNewswire/ Hanmi Pharmaceutical Co., Ltd. plans to create a global R&D achievement based on innovations of inflammation–fibrosis treatment, Triple-acting new drug for NASH (non-alcoholic steatohepatitis) treatment as well as various other innovations in metabolic disease, oncology and rare disease fields. What will be Hanmi s 2021 R&D strategy on new drugs Se Chang Kwon, the CEO of Hanmi Pharmaceutical Co., Ltd., is presenting the vision and strategy of Hanmi Pharmaceutical Co., Ltd. in 2021 at the 39th JP Morgan Conference.

Börse Express - Hanmi präsentiert Lösungspaket zur Bewältigung von COVID-19, einschließlich der Massenproduktion von Nukleinsäure-Impfstoffen (DNA

Börse Express - Hanmi präsentiert Lösungspaket zur Bewältigung von COVID-19, einschließlich der Massenproduktion von Nukleinsäure-Impfstoffen (DNA
boerse-express.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boerse-express.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.